Inogen Financial Statements
Inogen Financial Overview
Inogen's market cap is currently ―. The company's EPS TTM is $-0.88; its P/E ratio is -27.96; Inogen is scheduled to report earnings on August 9, 2022, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 80.39M | $ 76.40M | $ 93.11M | $ 101.56M | $ 86.93M |
| Gross Profit | $ 35.01M | $ 38.59M | $ 47.69M | $ 50.34M | $ 39.87M |
| EBIT | $ -13.59M | $ -6.67M | $ 6.37M | $ 11.67M | $ -2.13M |
| EBITDA | $ -7.83M | $ -906.00K | $ 11.90M | $ 16.91M | $ 2.97M |
| Net Income Common Stockholders | $ -14.21M | $ -22.88M | $ 12.17M | $ 5.10M | $ -732.00K |
| Balance Sheet | |||||
| Cash, Cash Equivalents and Short-Term Investments | $ 220.51M | $ 223.39M | $ 231.22M | $ 233.15M | $ 245.13M |
| Total Assets | $ 474.62M | $ 489.51M | $ 512.86M | $ 498.17M | $ 476.48M |
| Total Debt | $ 9.97M | $ 10.50M | $ 18.91M | $ 25.80M | $ 26.68M |
| Net Debt | $ -210.54M | $ -212.89M | $ -212.31M | $ -207.35M | $ -218.45M |
| Total Liabilities | $ 116.33M | $ 119.29M | $ 121.94M | $ 127.26M | $ 120.19M |
| Stockholders Equity | $ 349.62M | $ 352.50M | $ 356.28M | $ 358.29M | $ 370.23M |
| Cash Flow | |||||
| Free Cash Flow | $ -22.24M | $ 526.00K | $ -9.44M | $ 10.80M | $ -2.33M |
| Operating Cash Flow | $ -18.10M | $ 6.50M | $ -2.99M | $ 17.27M | $ 2.86M |
| Investing Cash Flow | $ -4.05M | $ -12.38M | $ 1.15M | $ -4.41M | $ 986.00K |
| Financing Cash Flow | $ -108.00K | $ -30.00K | $ 4.69M | $ 5.91M | $ 4.43M |